What Should Patients Know About NAD+ Injections?
Written by Evergreen Editorial, Evergreen Telehealth
Medically reviewed by Dr. Casey Greene, PharmD, IFMCP, Peptide Subject Matter Expert, Evergreen Telehealth
Published Updated
Quick Answer
NAD+ injections are clinician-prescribed shots, usually given under the skin, meant to raise NAD+ levels. Side effects reported in Evergreen's patient guide are usually mild: nausea, headache, redness, or a brief flushing sensation. Research showing that injected NAD+ improves energy or aging is limited, (3) and NAD+ is not FDA-approved for any medical indication, (2) so a clinician should review your health history and medicines first.

Introduction
NAD+ injections are small shots of nicotinamide adenine dinucleotide (NAD+), a molecule every cell uses to make energy and repair itself. A clinician prescribes them, and they are given under the skin. People look into them for energy, focus, and recovery as they get older.
The short, honest answer: the biology of NAD+ is well established, but research showing that injected NAD+ improves how people feel or age is still very limited. This guide explains how the injections are given, what research does and doesn't show, which side effects to expect, and who should be cautious.
What Are NAD+ Injections?
NAD+ is a coenzyme found in every cell. It helps turn food into usable energy and supports enzymes involved in DNA repair. Levels in tissue appear to decline with age, which is the main reason NAD+ has drawn so much interest in healthy-aging research. (1)
NAD+ injections deliver NAD+ itself. That is different from oral supplements such as nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN), which are precursors your body converts into NAD+. The difference matters because most human trial data involve oral precursors, not injected NAD+. (3) Want the basics of the molecule first? What Is NAD+ and Why Does It Matter for Cellular Health? →
NAD+ is not a hormone or a stimulant. The injectable form used in telehealth is typically a compounded medication, made for an individual patient by a licensed pharmacy. Compounded medicines are not FDA-approved, (2) and NAD+ is not FDA-approved for any medical indication. Your prescribing clinician decides, based on your individual medical needs, whether a compounded medicine is appropriate. To see how pharmacy-compounded products differ from unregulated "research" products, read why peptide quality and prices vary so much →.
How Are NAD+ Injections Given?
NAD+ injections are usually given subcutaneously: a small shot into the soft, fatty layer just under the skin of the belly or front of the thigh. Evergreen's patient guide describes one to two injections per week, starting at a low dose that your provider sets and adjusts. Your exact dose is personal to you and lives in your plan, not in a general article. A few habits make injections easier and help reduce risks:
- Rotate injection sites. Using a new site each time can reduce redness or tingling.
- Keep it clean. Wash your hands, wipe the vial top and your skin with an alcohol swab, and use a new syringe every time.
- Store it properly. Keep it refrigerated, never frozen, and out of the light. Follow the beyond-use date on your label, and discard a vial 28 days after first use.
- Dispose of sharps safely. Use a sharps container, and never reuse or share a syringe.
Some clinics also give NAD+ by IV infusion over several hours. This guide focuses on the subcutaneous injections used in at-home, clinician-guided care.
What Does the Research Show?
What is well supported. NAD+ plays essential roles in cellular energy and DNA repair. In human trials, oral precursors like NR and NMN consistently raise blood NAD+ levels, although improvements in how people function have been mixed and often absent. (3)
What is limited. A 2026 systematic review of 33 human studies, 28 of them randomized and nearly all using oral precursors, found no eligible outcome trials of intravenous or intramuscular NAD+ for anti-aging or wellness. (3) The first published human study of directly infused NAD+ was a small 2019 pilot in 11 men. It found that plasma NAD+ did not rise during the first two hours of a six-hour IV infusion, and it measured where NAD+ went in the body, not whether anyone felt or performed better. (4) A broader review also concluded that only a small number of adequately powered randomized trials of NAD-boosting strategies exist. (5)
What that means for you. Some people report steadier energy, clearer focus, or easier recovery on NAD+ injections. Those experiences are real to the people having them, but without placebo-controlled trials it is impossible to separate the effect of NAD+ from placebo, better sleep, or other lifestyle changes. Results vary, and you should not expect the same outcome as someone else.
What Side Effects Can NAD+ Injections Cause?
Most side effects reported with NAD+ injections are mild. Evergreen's patient guide lists:
- Nausea, headache, or tiredness. Tell your care team if these happen often. A lower dose may help.
- Redness or tingling where you inject. Common and usually fades. Rotating sites helps.
- A quick "rush." Warmth, flushing, mild pressure, or a rushing feeling can occur during or right after a shot, especially if it is injected quickly. Pushing the plunger in slowly usually helps, and it tends to fade within minutes.
Long-term safety data for injected NAD+ are limited, which is another reason ongoing clinical oversight matters.
Contact your care team if you have dizziness or a fast heartbeat that keeps coming back, especially if you take blood pressure medicine, or side effects that do not ease. Call 911 or go to the ER for chest pain or tightness, shortness of breath, a pounding heart that does not settle, swelling of the face, lips, tongue, or throat, a rash or hives with trouble breathing, or fainting.
Who Should Be Cautious or Talk With a Clinician First?
A licensed clinician should review your health history before NAD+ injections are considered. Situations that call for extra care include:
- Pregnancy or breastfeeding. NAD+ is not used during either.
- Heart disease. Your provider will review your plan first. NAD+ can lower blood pressure if the dose is too high.
- Certain medicines. Tell your clinician if you take medicine for diabetes, blood pressure, or depression, or a blood thinner, because NAD+ can affect how these work.
- Active cancer treatment. NAD+ is not used during active cancer treatment.
- Serious liver or kidney problems, or an organ transplant. Your provider will review your plan first.
This is a general overview, not a complete list, and a clinician makes the decision for each person. Not everyone will be a candidate for NAD+ injections. For eligibility and what the treatment process may involve, see the NAD+ Treatment Guide →.
Frequently Asked Questions
Are NAD+ injections FDA-approved? No. NAD+ is not FDA-approved for any medical indication, and compounded medicines are not FDA-approved as finished drug products. (2) They are made by licensed pharmacies for individual patients and prescribed after a clinician's evaluation.
How do NAD+ injections compare with NAD+ supplements like NMN or NR? Injections deliver NAD+ itself, while oral precursors (NR and NMN) have far more human trial data showing they raise NAD+ levels. (3) No large human trial has shown that one route produces better health outcomes than the other. (3)
How often are NAD+ injections given? It depends on the plan your provider builds. Evergreen's patient guide describes one to two times per week, starting low. Schedules and doses are individualized, so follow your prescription label and plan.
How long until I notice anything? No published trial has measured a timeline for injected NAD+, so no one can promise one. Some people report effects quickly and others notice nothing. Your care team will check in on how you are feeling. Learn more: How Long Does It Take to Notice Changes From Longevity Treatments? →
Can I use NAD+ injections with my other medicines? Tell your clinician about everything you take. NAD+ can affect how some diabetes, blood pressure, depression, and blood-thinning medicines work, so your provider needs the full picture.
Learn More About Evergreen Longevity
NAD+ is one of several approaches used in longevity medicine, and any treatment plan should be individualized and monitored by a licensed clinician. For the broader picture, read The Complete Guide to Longevity Treatments and Healthy Aging →.
Explore Clinician-Guided Longevity Care. Learn how Evergreen Longevity approaches healthy aging through individualized protocols and ongoing provider monitoring. Explore Evergreen Longevity →
Not every applicant will qualify for every treatment.
References
1. NAD+ decline with age: Reyna K, et al. Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting. Front Aging. 2026. https://pubmed.ncbi.nlm.nih.gov/41704678/
2. Compounded drugs and FDA approval: U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
3. Evidence for oral precursors and injected NAD+: Gallagher C, Emmanuel OO. NAD+ supplementation for anti-aging and wellness: a PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Res Rev. 2026. PMID 41655607. https://pubmed.ncbi.nlm.nih.gov/41655607/
4. Infused NAD+ in humans: Grant R, Berg J, Mestayer R, et al. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Front Aging Neurosci. 2019;11:257. https://pubmed.ncbi.nlm.nih.gov/31572171/
5. Clinical trial landscape: Clinical Evidence for Targeting NAD Therapeutically. Pharmaceuticals (Basel). 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7558103/
This page is for educational purposes only and is not a substitute for individualized medical advice. Always consult a licensed healthcare provider before starting or stopping any medication. Information and statements on this material have not been evaluated by the Food and Drug Administration. Evergreen Telehealth content is for general education and should never replace professional medical advice that considers your individual health.
Medically reviewed by Dr. Casey Greene, PharmD, IFMCP, Peptide Subject Matter Expert, Evergreen Telehealth, on November 17, 2026.